I think we have a very good chance to get some feedback from the FDA on CHF accelerated approval or single trial approval in April. The April or May out of the money options on MESO could be quite lucrative in this case.
Today’s buying is significant in my opinion. I think partially a short squeeze, however to me there seems like a few institutional buyers whom are accumulating quickly as they don’t want to miss out on some big upcoming catalysts.
FDA news would be a pleasant surprise. Also a major big pharma partnership.
I would be surprised about a “leak”, because to date Mesoblast has been incredibly good about keeping inside information safe.
Short Squeeze, page-58
-
- There are more pages in this discussion • 448 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.11 |
Change
-0.020(1.78%) |
Mkt cap ! $1.261B | |||
| Open | High | Low | Value | Volume |
| $1.12 | $1.13 | $1.09 | $4.556M | 4.141M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 9590 | $1.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.11 | 3132 | 1 |
View Market Depth
| Last trade - 16.10pm 18/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |